Cardinal Health found using ticker (CAH) have now 13 analysts covering the stock with the consensus suggesting a rating of ‘Hold’. The range between the high target price and low target price is between 75 and 53 calculating the average target price we see 61.46. Now with the previous closing price of 59.82 this now indicates there is a potential upside of 2.7%. There is a 50 day moving average of 57.23 and the 200 day moving average is 52.87. The market capitalisation for the company is $16,083m. Company Website: https://www.cardinalhealth.com
The potential market cap would be $16,524m based on the market concensus.
Cardinal Health operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. It has a collaboration agreement with Journey Biosciences Cardinal Health was founded in 1979 and is headquartered in Dublin, Ohio.
